Two-thirds of pharmaceutical companies did not proactively release the launch price of their medications from 2022 to 2024. Objective: To examine how drug manufacturers disclosed prices for new ...

The US Food and Drug Administration is rolling out a new program to speed up drug reviews by emphasizing clearer, more frequent communication with companies, aided by a surge of new hires. The agency ...

Hospitals rarely, if ever, receive advanced notice of drug shortages, which can make preparing for low inventory levels difficult. To ensure future shortages don’t hurt patient care, hospitals must ...